Showing results (271-280 of 283) with videos related to
Sort By:
Pageof 29
Eneuro|November 18, 2021
Precision Mapping of Amyloid-β Binding Reveals Perisynaptic Localization and Spatially Restricted Plasticity DeficitsHannah S Actor-Engel, Samantha L Schwartz, Kevin C Crosby, et al.Acta Crystallographica. Section D, Biological Crystallography|November 4, 2015
Structure and inhibition of subunit I of the anthranilate synthase complex of Mycobacterium tuberculosis and expression of the active complexGhader Bashiri, Jodie M Johnston, Genevieve L Evans, et al.Vaccine|June 30, 2005
Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3Stephen J Kent, C Jane Dale, Charani Ranasinghe, et al.Nature Genetics|March 19, 2013
POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemiaAndrew J Ramsay, Víctor Quesada, Miguel Foronda, et al.American Journal of Human Genetics|April 1, 2008
FISH mapping of de novo apparently balanced chromosome rearrangements identifies characteristics associated with phenotypic abnormalityJ A Fantes, E Boland, J Ramsay, et al.Trials|March 19, 2023
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)C McLeod, J Ramsay, K L Flanagan, et al.EMBO Reports|July 15, 2024
Novel immunomodulatory properties of adenosine analogs promote their antiviral activity against SARS-CoV-2Giulia Monticone, Zhi Huang, Peter Hewins, et al.Science Translational Medicine|December 6, 2019
Blood-brain barrier dysfunction in aging induces hyperactivation of TGFβ signaling and chronic yet reversible neural dysfunctionVladimir V Senatorov, Aaron R Friedman, Dan Z Milikovsky, et al.Nature Genetics|April 2, 2014
POT1 loss-of-function variants predispose to familial melanomaCarla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, et al.European Journal of Neurology|April 3, 2024
Real-world persistence of multiple sclerosis disease-modifying therapiesEmma C Tallantyre, Ruth Dobson, Joseph L J Froud, et al.Pageof 29